This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (16)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Effect on Patient Survival

William H. Wolberg, MD

AMA Arch Surg. 1974;109(2):211-214.

Abstract
Survival was determined in 41 patients whose tumors contained varying amounts of substances that inhibited leukocyte migration in vitro. Twenty-two of 28 patients whose tumors inhibited leukocyte migration less than 25% lived at least 24 months following diagnosis. Only three of 13 patients whose tumors inhibited leukocyte migration 25% or more survived for a similar period. Since tumor preparations inhibit migration of both autogenous and allogeneic leukocytes, the possibility of nonimmunologic mediation was considered. Leukocyte migration was inhibited by substances known to increase adenosine 3':5'-cyclic monophosphate. Production of such substances could be the mechanism by which tumor preparations inhibit leukocyte migration.

Author Affiliations
From the Department of Surgery, Division of Clinical Oncology, University of Wisconsin, Center for Health Sciences, Madison, Wis.

Footnotes
Accepted for publication April 2, 1974.

Read before the 31st annual meeting of the Central Surgical Association, Cincinnati, March 8, 1974.

Reprint requests to Department of Surgery, Division of Clinical Oncology, University of Wisconsin, Center for Health Sciences, 1300 University Ave, Madison, WI 53706 (Dr. Wolberg).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?